/PRNewswire/ Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the recent release of V-Wave s RELIEVE-HF.
Corvia s RESPONDER-HF Confirmatory Trial Supported By RELIEVE-HF Data menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
The mitral valve disease market size was valued at $2.5 billion in 2021, and is estimated to reach $5.7 billion by 2031, growing at a CAGR of 8.8% from 2022 to 2031.Drivers-The rising incidence of mitral valve disorders and the advancement of cutting-edge technologies for treating such conditions stand as crucial tr.
/PRNewswire/ Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced two-year results from its REDUCE.